Bruno Murer
Venice, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications
When RON MET TAM in Mesothelioma: All Druggable for One, and One Drug for All?
Journal: Frontiers in endocrinology
Published: October 30, 2018
Deregulation of miRNAs in malignant pleural mesothelioma is associated with prognosis and suggests an alteration of cell metabolism.
Journal: Scientific reports
Published: May 25, 2016
Reduction of estradiol in human malignant pleural mesothelioma tissues may prevent tumour growth, as implied by in in-vivo and in-vitro models.
Journal: Oncotarget
Published: February 23, 2016
Screening women for cervical cancer carcinoma with a HPV mRNA test: first results from the Venice pilot program.
Journal: British journal of cancer
Published: January 08, 2016
Induction of protein citrullination and auto-antibodies production in murine exposed to nickel nanomaterials.
Journal: Scientific reports
Published: November 11, 2015
Expression and activity of eIF6 trigger malignant pleural mesothelioma growth in vivo.
Journal: Oncotarget
Published: March 18, 2015
BAP1 (BRCA1-associated protein 1) is a highly specific marker for differentiating mesothelioma from reactive mesothelial proliferations.
Journal: Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc
Published: February 14, 2015
Differential p16/INK4A cyclin-dependent kinase inhibitor expression correlates with chemotherapy efficacy in a cohort of 88 malignant pleural mesothelioma patients.
Journal: British journal of cancer
Published: December 05, 2014
Well-differentiated papillary mesothelioma with invasive foci.
Journal: The American journal of surgical pathology
Published: March 13, 2014
Last Updated: 09/26/2026